Investor Presentaiton
Health Care
2-2. Health Care: Progress
THE KAITEKI COMPANY
■Inroads of generics into our long-term listed pharmaceuticals for healthcare usage
have been more than expected.
Will secure earnings expanding royalties from out-licensing of technology
and implementation of structural reforms
■In healthcare solutions, we will focus on creating new growth businesses.
Operating income (¥ billion)
120
100
80
60
60
40
40
20
20
70.0*
110.0
HHH
74.9
68.3
0
FY2012
Actual
FY2013
Actual
(Accumulated
through 3Q:
70.7)**
FY2014
Forecast
FY2015
Step 2 Plan
Mitsubishi Chemical Holdings
*Figure announced Nov. 27, 2014
**Figure announced Feb. 4, 2015
Businesses in Health Care
•
MTPC
.
LSII Group
-QKK
(Capsules,
pharmaceutical formulation materials, etc.)
-APIC
(Active pharmaceutical intermediates)
-LSIM
(Clinical testing,
support for pharmaceutical development, etc.)
-HLC
(Health self-check services, etc.)
16View entire presentation